Johnson & Johnson announced collaboration to expand manufacturing capabilities for its COVID-19 vaccine candidate
On Apr. 23, 2020, Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical of Johnson & Johnson…
-
-
Tyson Foods indefinitely suspended operations in Waterloo, Iowa
On Apr. 22, 2020, Tyson Fresh Meats, the beef and pork subsidiary of Tyson Food, planned to indefinitely…
-
BioNTech and Pfizer announced regulatory approval from German authority to commence first clinical trial of COVID-19 vaccine candidates
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
-
SNBL announced participation in development of a prophylactic DNA vaccine for COVID-19
On Apr. 20, 2020, SNBL announced their intention to participate in the development of a prophylactic DNA vaccine…
-
Vaxart announced positive preclinical data for ioral COVID-19 vaccine program
On Apr. 21, 2020, Vaxart announced it had obtained positive pre-clinical results for its COVID-19 vaccine candidates, with…
-
Deison Technology Park provided increased capacity for VGXI to manufacture vaccines
On Apr. 20, 2020, VGX signed as the first occupant of Conroeﾒs Deison Technology Park and will move…
-
COVID-19 | Diagnostics | Infectious Disease | Therapeutics | USDA | Vaccine
Tyson Fresh Meats resumed limited operations at Columbus Junction Pork Plant
On Apr. 20, 2020, Tyson Fresh Meats resumed limited operations at its pork plant in Columbus Junction, Iowa,…
-
Biotechnology | Disease | Influenza | Therapeutics | Vaccine
Celdara Medical entered into a CRADA with USAMRIID and the Geneva Foundation
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
-
Five Oxford University COVID-19 projects received UK Research and Innovation funding
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
-
Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
-
Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
-
Biotechnology | COVID-19 | NIH | Vaccine
Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…
-
COVID-19 | Infectious Disease | NIH | Vaccine
IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
-
COVID-19 | FDA | Infectious Disease | Vaccine
Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine
On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced that…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
-
Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 16, 2020, the U.S. government announced it will fund development of an experimental coronavirus vaccine from…
-
Soligenix announced exclusive licensing agreement for novel vaccine adjuvant from BTG Specialty Pharmaceuticals
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
-
FDA accepted for Priority Review Biologics License Application for REGN-EB3 to treat Ebola
On Apr. 16, 2020, Regeneron announced the U.S. Food and Drug Administration (FDA) had accepted for Priority Review…
-
Biotechnology | COVID-19 | Diagnostics | Medicine | Therapeutics | Vaccine
The Bill & Melinda Gates Foundation expands its commitment to global COVID-19 response
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
-
U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19
On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…
-
Abbott launched third COVID-19 test, a laboratory-based antibody blood test
On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…
-
HALIX entered collaboration with University of Oxford for GMP manufacturing of a COVID-19 vaccine
On Apr. 15, 2020, HALIX announced it had joined a consortium of partners under the guidance of the…
-
Microneedle coronavirus vaccine triggered immune response in mice
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
-
Sanofi and GSK announced an unprecedented vaccine collaboration to fight COVID-19
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
-
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
-
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
-
Biology | Diagnostics | Infectious Disease | Life Science History | Medicine | Pharmaceutical | Radiology | Therapeutics | U.S. Congress | Vaccine
The US Veterans Affairs established the department’s first history office
On Apr. 10, 2020, the U.S. Department of Veterans Affairs (VA) established the VA History Office (VAHO) to…
-
Pfizer and BioNTech announced details on collaboration to accelerate global COVID-19 vaccine development
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
-
iBio announced signing of agreements with Infectious Disease Research Institute in support of iBio’s SARS-CoV-2 Virus-Like Particle vaccine development
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
-
Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}